Richard J. Hawkins
CIK: 0001307632
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Oct 1, 2026CNSY
CERENOME, INC.
Exercise(M)Direct921 shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct922 shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
3.7K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
3.7K shares- - Dec 9, 2025SVRA
Savara Inc
Award(A)Direct40K shares- - Nov 14, 2025SVRA
Savara Inc
Exercise(M)Direct5.9K shares at avg. $1.46$9K - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
397.8K shares- - Jun 20, 2025SVRA
Savara Inc
Purchase(P)Direct48.2K shares at avg. $2.04$99K - Feb 18, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
40.1K shares- - Dec 16, 2024SVRA
Savara Inc
Sale(S)Direct8K shares at avg. $3.32$27K - Dec 12, 2024SVRA
Savara Inc
Award(A)Direct40K shares- - Dec 12, 2024(LUMO)
LUMOS PHARMA, INC.
Disposition(D)Direct753.1K shares- - Dec 12, 2024(LUMO)
LUMOS PHARMA, INC.
Disposition(D)Indirect4.5K shares- - Sep 13, 2024PSTV
PLUS THERAPEUTICS, INC.
Purchase(P)Direct4K shares at avg. $1.50$6K - Sep 12, 2024PSTV
PLUS THERAPEUTICS, INC.
Purchase(P)Direct6.3K shares at avg. $1.35$9K - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
3.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  CNSY CERENOME, INC. | Exercise(M) | 921 | - | $0 | Direct |
| Jul 1, 2026 |  PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 922 | - | $0 | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 3,686 | - | - | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 3,686 | - | - | Direct |
| Dec 9, 2025 |  SVRA Savara Inc | Award(A) | 40,000 | - | - | Direct |
| Nov 14, 2025 | SVRA Savara Inc | Exercise(M) | 5,860 | $1.46 | $8,556 | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 397,794 | - | - | Direct |
| Jun 20, 2025 | SVRA Savara Inc | Purchase(P) | 48,225 | $2.04 | $98,572 | Direct |
| Feb 18, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 40,122 | - | - | Direct |
| Dec 16, 2024 | SVRA Savara Inc | Sale(S) | 8,000 | $3.32 | $26,569 | Direct |
| Dec 12, 2024 | SVRA Savara Inc | Award(A) | 40,000 | - | $0 | Direct |
| Dec 12, 2024 | /logo?size=32) (LUMO) LUMOS PHARMA, INC. | Disposition(D) | 753,093 | - | $0 | Direct |
| Dec 12, 2024 | (LUMO) LUMOS PHARMA, INC. | Disposition(D) | 4,469 | - | $0 | Indirect |
| Sep 13, 2024 | PSTV PLUS THERAPEUTICS, INC. | Purchase(P) | 4,000 | $1.50 | $5,996 | Direct |
| Sep 12, 2024 | PSTV PLUS THERAPEUTICS, INC. | Purchase(P) | 6,285 | $1.35 | $8,512 | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 3,650 | - | - | Direct |
1-16 of 16 transactions
About Hawkins Richard J
Hawkins Richard J (SEC CIK 0001307632) files insider reports with the SEC as Director of CERENOME, INC. (CNSY), Director of Savara Inc (SVRA) and Chief Executive Officer of LUMOS PHARMA, INC. ((LUMO)).
Signal8 holds 13 ownership filings by Hawkins Richard J, all Form 4s, filed between Sep 12, 2024 and Oct 1, 2026. Those filings report 16 transactions, from Sep 11, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hawkins Richard J's filings is in HOUSTON, TX.
Recent filings by Hawkins Richard J
- Oct 1, 2026: Option exercise of CNSY shares (Form 4, code M).
- Jul 1, 2026: Option exercise of PSTV shares (Form 4, code M).
- May 14, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
- Dec 9, 2025: Grant or award of SVRA shares (Form 4, code A).
- Nov 14, 2025: Option exercise of SVRA shares (Form 4, code M).
Other insiders filing for CERENOME, INC. (CNSY)
- van Es-Johansson An, Director
- Clowes Howard, Director
- Sims Andrew John Hugh MacIntyre, Chief Financial Officer
- HEDRICK MARC H, Chief Executive Officer
- ANDREWS RONALD ASBURY, Director
- Guse Kyle, Director